Pharmacyclics announces clinical abstracts on ibrutinib to be presented at ASCO annual meeting
Pharmacyclics, Inc. today announced that clinical abstracts on Bruton’s Tyrosine Kinase inhibitor, ibrutinib have been selected for oral presentations at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Jun... read more...
Health Canada approves Osiris’ Prochymal to treat acute GvHD in children
Osiris Therapeutics Inc. announced today it has received market authorization from Health Canada to market its stem cell therapy Prochymal (remestemcel-L), for the treatment of acute graft-vs-host disease (GvHD) in children.Full Article : T... read more...
State budgets aim at health programs, Medicaid to bridge shortfalls
Medicaid and other health program cuts are on the minds of state lawmakers around the nation. In Maine, the governor signed Medicaid cuts into law Wednesday, and California and Kansas are weighing similar cuts as they struggle to balance th... read more...